heel stick Latest News

The Medical Device's Trademark is Also Registered in the United States, Australia, China, South Korea, Singapore and Switzerland

More Than 140 Neonatal Nurses and Educators Entered Daily Drawing

Attendees Can Earn Entries by Evaluating the babyLance Heel Incision Device at MediPurpose Booth 436

Medikus, a Semi-Exclusive Distributor for babyLance in Austria, has Partnered with Medipurpose Since December 2010

Equivalent of U.S. FDA Registration, CA Registration Enables Distribution of babyLance in Italy

Launched last July, babyLance is a single-use heel incision device utilized to obtain a blood sample from the heels of newborn (babyLance BLN) and preemie (babyLance BLP) infants.

MediPurpose(r), a master distributor and manufacturer of medical products, today announced Medikus as the exclusive Austrian distributor for its babyLance(r) infant heel incision device.

MediPurpose®, a master distributor and manufacturer of medical products, today announced that its trademark for the babyLance® infant heel incision device has been registered with the United States Patent and Trademark Office.

‘Ease of Use’ a Factor in NICU Manager’s Decision

First Canadian Distributor for babyLance™ Heel Incision Devices